← Open Payments lookup

JOANNA MARMARO: Open Payments

NPI 1104363142 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$740 in 33 payments from 21 companies in 2025. Trend: 2023 $313 · 2024 $334 · 2025 $740

Food & beverage: $740
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP9$210
Janssen Biotech, Inc.3$55
Geron Corporation2$47
Novartis Pharmaceuticals Corporation2$43
Genmab U.S., Inc.1$28
GlaxoSmithKline, LLC.1$28
Aveo Pharmaceuticals, Inc.1$27
Incyte Corporation1$27
BeOne Medicines USA, Inc.1$26
Regeneron Healthcare Solutions, Inc.1$26

Products named: IMFINZI, ENHERTU, EPKINLY, RYTELO, SCEMBLIX, RYBREVANT, PADCEV, OJJAARA.

Industry payments across TX — which companies pay providers there.